http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-18-2008/0004834735&EDATE=
<p>CLEVELAND, June 18 /PRNewswire/ — Synapse Biomedical Inc. announced today it has received approval from the U.S. Food and Drug Administration (FDA) for its NeuRx DPS(TM) for ventilator-dependent Spinal Cord Injury (SCI) patients who lack voluntary control of their diaphragms. With the FDA’s approval, SCI patients and their caregivers…</p>